Form 4: Perspective Therapeutics Director Lori A. Woods Increases Stake in Company

Director Lori A. Woods reports purchasing 23,475 shares of Perspective Therapeutics at $2.1299 per share, increasing her indirect holdings.

Summary

• On March 31, 2025, Lori A. Woods, a director of Perspective Therapeutics, Inc. [CATX], acquired 23,475 shares of common stock at a price of $2.1299 per share.
• The shares were acquired indirectly through the Woods Family Living Trust.
• Following the transaction, Woods' indirect beneficial ownership increased to 183,460 shares.
• Woods also directly owns 4,807 shares of common stock.

Sentiment

Score: 6

Explanation: Insider buying is generally viewed as a positive sign, suggesting confidence in the company's prospects. However, the impact is moderate as it's a single transaction and the overall holdings are not significantly altered.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares of their company's stock. It provides transparency to the market regarding insider transactions.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal.

Key Dates

Keywords

Perspective Therapeutics, CATX, Lori A. Woods, Director, Stock Purchase, Beneficial Ownership, Form 4